As seen in the DESTINY-Breast06 trial, approximately 20-25 percent of hormone receptor (HR)-positive, HER2-negative breast ...

Q3 2024 Management View Revenue for Q3 FY2024 increased 16.6% year-on-year to ¥1,367.6 billion, driven by growth in oncology ...

Basel: Roche has announced that the U.S. Food and Drug Administration (FDA) has approved a label expansion for the PATHWAY ...

Roche’s PATHWAY HER2 (4B5) test helps identify patients with HER2-ultralow breast cancer, who may be eligible for targeted ...

Nolan married her husband of more than two decades, Brian Hudson, in the Blackpool church, and said goodbye to him there ...

Members of the public are also welcome to gather at the church for the service at 10.30am on Saturday at St Paul’s Church in ...

Actor Shane Richie was among the first people to arrive for the funeral of Linda Nolan in Blackpool. The service at St Paul’s ...

Daiichi Sankyo appoints Hiroyuki Okuzawa as chief executive officer: Tokyo Saturday, February 1, 2025, 12:30 Hrs [IST] ...

The Nolans star, known by many TV fans for her Celebrity Big Brother appearance and by others as a theatre performer, was ...

Linda Nolan's funeral will be held today as her family and friends celebrate her "remarkable life". Members of the public are welcome to pay their respects at the church for the service at 10.30am on ...

The Swiss pharmaceutical company said the FDA backed a label expansion for the Pathway HER2 (4B5) test to identify patients with HR-positive, HER2-ultralow metastatic breast cancer who could be ...